Erosion of teeth
Conditions
Interventions
A therapy to reduce dentin hypersensitivity in non-carious cervical lesions will be applied. Among the therapies will be the low power laser and oxalate.
There were three groups: G1 oxalate gel (Kota
Other
D002129
Sponsors
Universidade de Brasília
Corpo de Bombeiros Militar do Distrito Federal
Eligibility
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: Patients who present at least one LCNC with HDC; Both sexes; Age range: from 18 to 60 years; Do not have had home treatment in the last month with dentifrices / pastes / creams or mouthwashes indicated for the treatment of dentine hypersensitivity, having in their composition: potassium nitrate, oxalates, strontium, bicarbonate of arginine or 5000 ppm / F; Not having performed office treatment with desensitizing agents for professional use such as lacquer, gels and laser therapy in the last month; Do not use anti-inflammatory or analgesics during treatment
Exclusion criteria
Exclusion criteria: Patients with LCNC, but without HCD; Use of continuous anti-inflammatory and analgesic medications; Use of orthodontic appliance; Presence of periodontitis or active carious lesion; Pregnant or nursing; Continuously use toothpaste / paste / creams or mouthwashes indicated for the treatment of dentine hypersensitivity, having in their composition: potassium nitrate, oxalates, strontium, arginine bicarbonate or 5000 ppm / F; Very deep LCNCs being possible to visualize the shade of the pulp chamber, indicated restorative treatment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The expected outcome is the reduction in dentin hypersensitivity in patients with non-carious cervical lesions and if there is a significant difference between the types of therapy experienced. The method used to verify the reduction of dentin hypersensitivity in non-carious cervical lesions will be the two stimuli: evaporative stimulus - Air Jet Exposure Time (TEJA) and a tactile stimulus (ET) After the stimulus, the patient will indicate the level of sensitivity experienced on a pain scale from 0 to 10 Visual Analogue Scale (VAS) At the end of the therapy, the minimum reduction of one point in the scale is desired. | — |
Secondary
| Measure | Time frame |
|---|---|
| The expected outcome is to verify if there is an improvement in patients' quality of life, to evaluate if there is an association between non-carious cervical lesions (LCNC) and cervical dentinal hypersensitivity, to verify if desensitizing therapy is more efficient than the other and to promote a change in deleterious habits that patients may present The methods used to evaluate secondary outcomes will be quality of life questionnaires, anamnesis evaluation and clinical data evaluation The presentation of the parameters such as Silness & Löe Index (visible plaque index), CPOD index (caries, lost, filled, tooth measurement unit) and classification of lesion morphology and dimensions will be used to verify if there is a significant correlation between the lesions cervical lesions (LCNCs) and the type of dentin sensitivity | — |
Countries
Brazil
Contacts
Public ContactPaula Sgreccia
Corpo de Bombeiros Militar do Distrito Federal
Outcome results
None listed